Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes

William J. Archibald, Kari G. Rabe, Brian Kabat, Joerg Herrmann, Wei Ding, Neil E. Kay, Saad S. Kenderian, Eli Muchtar, José F. Leis, Yucai Wang, Asher Chanan‐Khan, Susan M. Schwager, Amber B. Koehler, Amie Fonder, Susan L. Slager, Tait D. Shanafelt, Timothy G. Call, Sameer A. Parikh